Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04885166 · ClinicalTrials.gov registry record · NA

Preventing Prescription Stimulant Diversion and Medication Misuse Via a Web-Based Simulation Intervention

A NA study of Prescription Drug Abuse (Not Dependent) and Intentional Misuse, sponsored by Trinity College.

Completed
Registry status
NA
Development phase
249
Enrollment target
3
Study locations

NCT04885166: Completed NA study of Prescription Drug Abuse (Not Dependent) and Intentional Misuse, sponsored by Trinity College.

NCT04885166 is a NA study of Prescription Drug Abuse (Not Dependent) and Intentional Misuse that has completed, run by Trinity College. The registered enrollment target is 249 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04885166, a NA study of Prescription Drug Abuse (Not Dependent) and Intentional Misuse, has completed, sponsored by Trinity College.

COMPLETED
Registry status
NA
Development phase
249 participants
Enrollment target
3
Study locations

Study Summary

Half or nearly half of college students with prescriptions divert their stimulant medication, and a similarly high percentage misuse their medication or use someone else's prescription. Diversion may lead students to go without needed medication to mitigate their symptoms, increasing their risk for unintentional injuries and substance use. Further, diversion perpetuates the non-medical use of prescription stimulants (NMUPS), which has become increasingly common among college students. Diversion also perpetuates medical misuse of stimulants among students with prescriptions, which is associated with poorer attention-deficit/hyperactivity disorder (AD/HD) symptom management and may increase the risk for addictive disorders. There are no evidence-based interventions targeting diversion of stimulants in college students. Being approached for one's medication is a key risk factor for diversion, as is medication non-adherence and believing NMUPS and diversion are more prevalent than they are. Accordingly, in this multi-site study, the investigators will conduct a randomized, controlled trial of 300 college-attending adults with current stimulant prescriptions to examine the preliminary efficacy and feasibility of a single-session, computer-based simulation intervention (with two booster sessions) to prevent prescription stimulant diversion and medication misuse and compare it to a placebo condition. The intervention, which is grounded in social learning theory and the theory of planned behavior uniquely engages students in interactive discussions with virtual humans to (a) learn about the actual prevalence of NMUPS and diversion and their related risks, (b) practice using refusal strategies when approached for their medication in high-risk situations, and (c) understand how to effectively communicate with prescribers and avoid medication misuse. The primary aims are to determine if the intervention reduces diversion, intentions to divert, and medication misuse, and to ass

Primary Outcome

participants will note how many times they have engaged in diversion (i.e., giving away, selling, or trading one's prescribed medication)

Interventions

  • OTHER Web-based placebo presentation
  • BEHAVIORAL Web-based simulation active intervention

Study Locations (3)

Connecticut

  • Trinity College - Hartford

Texas

  • Texas State University - San Marcos

Wyoming

  • University of Wyoming - Laramie

Trial Details

FieldValue
Enrollment Target 249 participants
Start Date 2021-05-04
Est. Completion 2024-05-21
Phase NA
Trinity College

1 total trials

What the finished NCT04885166 record still lists

NCT04885166 is an interventional study that assigns participants to a tested intervention. The registered 249 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower).

The record links to 2 conditions, with Prescription Drug Abuse (Not Dependent) appearing as the primary indexed condition, and to 2 interventions - of which Web-based placebo presentation is the first listed.

NCT04885166 reports a single indexed study location in Connecticut, Texas, Wyoming.

Frequently Asked Questions

What is clinical trial NCT04885166 about?

NCT04885166 is a clinical study titled "Preventing Prescription Stimulant Diversion and Medication Misuse Via a Web-Based Simulation Intervention". Half or nearly half of college students with prescriptions divert their stimulant medication, and a similarly high percentage misuse their medication or use someone else's prescription. Diversion may lead students to go without needed medication to mitigate their symptoms, increasing their risk for ...

What is the current status of trial NCT04885166?

This trial is currently completed. It is a NA study. The enrollment target is 249 participants. The study started on 2021-05-04. Estimated completion is 2024-05-21.

What conditions does trial NCT04885166 study?

This clinical trial studies the following conditions: Prescription Drug Abuse (Not Dependent), Intentional Misuse.

What interventions are being tested in trial NCT04885166?

The interventions under investigation include: Web-based placebo presentation (OTHER), Web-based simulation active intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT04885166?

This trial is sponsored by Trinity College, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04885166 being conducted?

This trial has 3 study locations across Connecticut, Texas, Wyoming. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

How this trial's enrollment target compares

Where NCT04885166's enrollment target sits among peer trials

249 434th of 2000 higher than 1,567 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04628767 · 249 participants · Phase 2

    Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer

  • NCT05834907 · 249 participants · NA

    Hands and Hearts Together

  • NCT06067555 · 249 participants · Early Phase 1

    Intradermal Influenza Vaccination

  • NCT06588478 · 249 participants · Phase 2

    A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04885166, the US trial registry maintained by the National Library of Medicine. NCT04885166 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.